Home › Male Infertility › NCT04452305
Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting
Recruiting
Who can join
All ages · Men
Full eligibility criteria
Inclusion Criteria: * Male participant at least in Tanner stage 3 * Previously cryopreserved and stored testicular tissue/cells (frozen due to an infertility-risking diagnosis or treatment such as chemotherapy or radiation) available for autologous transplantation and grafting * Healthy enough to undergo anesthesia * Written clearance for the procedure from the patient's hematologist or oncologist to confirm the patient has finished treatment for primary condition and are clear to undergo autologous stem cell transplant Exclusion Criteria: * Participants considered to be high risk for surgical complications * Participants with a history of leukemia, lymphoma or testicular cancer or a cancer that likely involved testicles at the time of testicular tissue collection * Diagnosed with psychological, psychiatric, or other conditions which prevent giving fully informed consent.
About the study
Spermatogonial stem cell transplantation through ultrasound guided rete testis injection and testicular tissue grafting will be performed for participants who have frozen testicular tissue prior to gonadotoxic therapy. The purpose of this study is to test the safety and feasibility of these transplant technologies and restore fertility for these participants.
What is being tested
- Spermatogonial Stem Cell Transplant and Testicular Tissue Grafting (procedure)
Sponsor: University of Pittsburgh · Participants: 10 · Started: Nov 10, 2023
Contact the study team
- Jennifer L Anglin · Phone: 412-641-7475
Official record on ClinicalTrials.gov — NCT04452305
Locations in the U.S.
| Pennsylvania | Magee-Womens Hospital, Pittsburgh |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.